We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEO icon
1351
American Eagle Outfitters
AEO
$3.01B
– –
-41,934
Closed -$704K
AEP icon
1352
American Electric Power
AEP
$68.4B
– –
-21,584
Closed -$2.15M
AEVA
1353
Aeva Technologies
AEVA
$1.82B
– –
-6,913
Closed -$150K
AFG icon
1354
American Financial Group
AFG
$12.1B
– –
-1,982
Closed -$289K
AFYA icon
1355
Afya
AFYA
$1.27B
– –
-48,141
Closed -$694K
AIV
1356
Aimco
AIV
$383M
– –
-31,762
Closed -$232K
AIZ icon
1357
Assurant
AIZ
$14.3B
– –
-1,567
Closed -$285K
AKAM icon
1358
Akamai
AKAM
$16.1B
– –
-1,962
Closed -$234K
AKBA icon
1359
Akebia Therapeutics
AKBA
$252M
– –
-54,370
Closed -$39K
ALB icon
1360
Albemarle
ALB
$15.5B
– –
-1,060
Closed -$234K
ALDX icon
1361
Aldeyra Therapeutics
ALDX
$93.5M
– –
-59,934
Closed -$266K
ALEC icon
1362
Alector
ALEC
$198M
– –
-12,984
Closed -$185K
ALK icon
1363
Alaska Air
ALK
$5.58B
– –
-13,425
Closed -$779K
ALLO icon
1364
Allogene Therapeutics
ALLO
$694M
– –
-148,804
Closed -$1.36M
ALNY icon
1365
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-2,554
Closed -$417K
ALRM icon
1366
Alarm.com
ALRM
$2.85B
– –
-9,003
Closed -$598K
AMD icon
1367
Advanced Micro Devices
AMD
$789B
– –
-4,101
Closed -$448K
AMKR icon
1368
Amkor Technology
AMKR
$13.7B
– –
-24,418
Closed -$530K
GOLD
1369
Gold.com Inc
GOLD
$1.26B
– –
-7,426
Closed -$287K
AMR icon
1370
Alpha Metallurgical Resources
AMR
$1.93B
– –
-2,790
Closed -$368K
AMWL icon
1371
American Well
AMWL
$230M
– –
-4,141
Closed -$349K
AMZN icon
1372
Amazon
AMZN
$2.96T
– –
-18,840
Closed -$3.07M
AN icon
1373
AutoNation
AN
$6.92B
– –
-2,616
Closed -$261K
ANIP icon
1374
ANI Pharmaceuticals
ANIP
$1.78B
– –
-8,920
Closed -$251K
AOSL icon
1375
Alpha and Omega Semiconductor
AOSL
$1.08B
– –
-7,284
Closed -$398K
53 54
55
56 57

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.